The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations
CONCLUSION: Clinical breast examination did not increase the number of breast cancers detected in MRI-screened women with BRCA1/2 mutations. Removing breast examination from surveillance programs that include MRI may be reasonable for these women.PMID:34420218 | DOI:10.5694/mja2.51226
Source: Medical Journal of Australia - Category: General Medicine Authors: Tamara Hettipathirana Courtney Macdonald Jing Xie Kate Moodie Chris Michael Kelly-Anne Phillips Source Type: research
More News: Australia Health | Breast Cancer | Cancer | Cancer & Oncology | General Medicine | Mammography | Mastectomy | MRI Scan | Ovarian Cancer | Ovaries | Study | Women